FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称PINATUZUMAB VEDOTIN
异名/同义词ACD22-VCMMAE
ACD-22VCMMAE
ACD-22-VCMMAE
ANTI-CD22-MONOMETHYL AURISTATIN E ANTIBODY-DRUG CONJUGATE
FCU-2703
IMMUNOGLOBULIN G1-KAPPA AURISTATIN E CONJUGATE, ANTI-(HOMO SAPIENS CD22 (SIALIC ACID BINDING IG-LIKE LECTIN 2, SIGLEC2, SIGLEC-2, BLYMPHOCYTE CELL ADHESION MOLECULE, BL-CAM, LEU-14)), HUMANIZED MONOCLONAL ANTIBODY CONJUGATED TO AURISTATIN E
PINATUZUMAB VEDOTIN
PINATUZUMAB VEDOTIN [INN]
PINATUZUMAB VEDOTIN [USAN]
PINATUZUMAB VEDOTIN [WHO-DD]
RG-7593
RO5541072-000
RO-5541072000
DCDT2980S
DCDT-2980S
FCU2703
RO-5541072-000
CAS登记号1313706-14-7
物质唯一标识(Unique Ingredient Identifier)6KA1906BLC
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System